Virtual visit appointments available 7 days a week from 9:00am to 11:00pm. Learn More
Texas Medical Center
Specialty
Cancer and Hematology
Phone: 832-822-4306
Fax: 832-825-1503
Email
msu@bcm.edu
Address
6701 Fannin St., Ste. 1510
Houston, TX 77030
Jack Meng-Fen Su, MD
Associate Professor, Department of Pediatrics, Section of Hematology/Oncology, Baylor College of Medicine
Hyundai Pediatric Cancer Research Scholar
Education
| School | Education | Degree | Year |
|---|---|---|---|
| Baylor College of Medicine | Masters | Master of Science, Clinical Investigation | 2007 |
| Baylor College of Medicine | Fellowship | Pediatric Oncology Clinical Research | 2006 |
| Baylor College of Medicine | Fellowship | Pediatric Hematology-Oncology | 2001 |
| University of California School of Medicine (San Francisco) | Residency | Pediatrics | 1997 |
| University of California, San Francisco | Medical School | Doctor of Medicine | 1990 |
| Stanford University | Bachelors | Bachelor of Science, Chemistry | 1986 |
About
Dr. Jack Su's clinical interest is in neuro-oncology.
Board Certifications
American Board of Pediatrics
American Board of Pediatrics - Pediatric Hematology-Oncology
Organizations
| Organization Name | Role |
|---|---|
| American Association of Cancer Research (AACR) | Member |
| Pediatric Brain Tumor Consortium (PBTC) | Member |
| Society of Neuro-Oncology | Member |
Research Statement
Dr. Jack Su's research interest is in translational oncology and developing novel agents for treating pediatric CNS tumors. Dr. Su is currently conducting a Children's Oncology Group (COG) phase I study of valproic acid in children with recurrent solid tumors, including brain tumors. He is also developing clinical trials of additional histone deacetylase (HDAC) inhibitors, such as suberoylanilide hydroxamic acid (SAHA), and a poly(ADP-ribose) polymerase (PARP) inhibitor for pediatric CNS tumors.
Dr. Su is conducting pre-clinical studies of HDAC inhibitors, PARP inhibitors, and DNA methylation inhibitors for future clinical trials in pediatric CNS tumors.His research interests are in translational oncology and developing novel agents for treating pediatric CNS tumors.
Selected Publications
Language
English, Chinese
* Texas Children's Hospital physicians' licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician's office and were not verified by Texas Children's Hospital.